Suppr超能文献

MELD 评分用于心脏手术中的风险分层。

MELD-score for risk stratification in cardiac surgery.

机构信息

Universitätsklinikum Erlangen, Herzchirurgische Klinik, Krankenhaus Straße, 12, 91054, Erlangen, Germany.

Chair of Spatial Data Science and Statistical Learning, Georg-August-Unversität Göttingen, Wilhelmsplatz, 1, 37073, Göttingen, Germany.

出版信息

Heart Vessels. 2023 Sep;38(9):1156-1163. doi: 10.1007/s00380-023-02262-9. Epub 2023 Apr 1.

Abstract

The outcome of the patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) is also influenced by the renal and hepatic organ functions. Risk stratification, using scores such as EURO Score II or STS Short-Term Risk Calculator for patients undergoing cardiac surgery with cardiopulmonary bypass, ignores the quantitative renal and hepatic function; therefore, MELD-Score was applied in these cases. We retrospectively examined patient data using the MELD score as a predictor of mortality. To perform a univariate analysis of the data, patients were classified into three groups based on the MELD Score: MELD < 10 (Group 1), MELD 10 to 19 (Group 2), and MELD ≥ 20 (Group 3). A total of 11,477 participants were included in the study, though several patients with either missing MELD scores or lack of creatinine, bilirubin, or INR levels were dropped from the original cohort. Eventually, 10,882 patients were included in the analysis. The primary outcome was defined as postoperative, in-hospital mortality. Secondary outcomes such as postoperative bleeding, including the requirement for repeat thoracotomy, postoperative neurological complications, and assessment of catecholamines on weaning from cardiopulmonary bypass/ requirement of mechanical circulatory support were examined. A higher MELD score was associated with increased postoperative mortality. Patients with MELD > 20 experienced a 31.2% postoperative mortality, compared to Group 1 (4.6%) and Group 2 (17.5%). The highest rates of postoperative bleeding (13.8%) and, repeat thoracotomy (13.2%) & postoperative pneumonia (17.4%) were seen in Group 3 (threefold increase when compared to Group 1, renal failure requiring dialysis (N = 235, 2.7% in Group 1 v/s N = 78, 22.9% in Group 3) or requiring high dose catecholamines post-operatively or mechanical circulatory support (IABP/ECLS). Incidentally, an increased MELD Score was not associated with a significant increase in the postoperative incidence of stroke/TIA or the presence of sternal wound infections/complications. A higher mortality was observed in patients with reduced liver and renal function, with a significant increase in patients with a MELD score > 20. As the current risk stratification scores do not consider this, we recommend applying the MELD score before considering patients for cardiac surgery.

摘要

接受体外循环心脏手术的患者的预后结果也受到肾功能和肝功能的影响。风险分层,使用 EURO Score II 或 STS 短期心脏手术风险计算器等评分系统,忽略了肾功能和肝功能的定量指标;因此,在这些情况下应用了 MELD 评分。我们回顾性地使用 MELD 评分作为死亡率的预测因子来检查患者数据。为了对数据进行单因素分析,根据 MELD 评分将患者分为三组:MELD<10(组 1)、MELD 10-19(组 2)和 MELD≥20(组 3)。共有 11477 名参与者被纳入研究,但由于 MELD 评分缺失或缺乏肌酐、胆红素或 INR 水平,一些患者从原始队列中被剔除。最终,10882 名患者被纳入分析。主要结局定义为术后院内死亡率。次要结局包括术后出血,包括需要再次开胸、术后神经系统并发症以及体外循环脱机时儿茶酚胺的评估/需要机械循环支持。MELD 评分越高,术后死亡率越高。MELD>20 的患者术后死亡率为 31.2%,而组 1(4.6%)和组 2(17.5%)。术后出血发生率最高(13.8%),再次开胸(13.2%)和术后肺炎(17.4%)发生率最高的是组 3(与组 1相比增加了三倍)、需要透析的肾衰竭(N=235,占组 1的 2.7%,N=78,占组 3 的 22.9%)或术后需要高剂量儿茶酚胺或机械循环支持(IABP/ECLS)。有趣的是,MELD 评分增加与术后中风/TIA 发生率或胸骨伤口感染/并发症的显著增加无关。肝功能和肾功能降低的患者死亡率较高,MELD 评分>20 的患者显著增加。由于目前的风险分层评分系统没有考虑到这一点,我们建议在考虑患者接受心脏手术之前应用 MELD 评分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1123/10372113/a1d67fdd13c0/380_2023_2262_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验